Skip to main content
Premium Trial:

Request an Annual Quote

Biotage Cuts to Total Around 65 as Firm Preps US Move

NEW YORK (GenomeWeb News) – Biotage expects to cut around 65 jobs at its Charlottesville, Va., facilities rather than the 50 it had initially estimated when it announced the layoffs in January.

A Biotage spokesperson told GenomeWeb Daily News today that the firm had around 75 employees in Charlottesville before the initial round of layoffs was announced. She said the cuts were being made in waves a few months apart.

The firm will retain around 10 employees, who will move to the firm's new US office in North Carolina in Sepember. However, the new facility will not have any production capabilities, with employees focused on administrative tasks, distribution, and sales, she said.

Uppsala, Sweden-based Biotage said in January that it would move its instrument production from its current facilities in Charlottesville to an unnamed contract manufacturer. The instruments made at that facility are primarily for purification applications. A small portion of the firm's consumables also are made at the Virginia facility, but production of those products are being moved to Biotage's facility in Cardiff, Wales, which already manufactures the majority of its consumables.

Filed under

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.